The Italian market for hormones in dosage, excluding contraceptives and antibiotics, was valued at approximately $7.36 billion in 2023. Forecasts indicate a steady growth trend from 2024 to 2028, with market size values rising from $7.48 billion in 2024 to $7.92 billion in 2028, reflecting a compound annual growth rate (CAGR) of approximately 1.4% annually.

Notable trends:

Year-on-year growth is consistent, demonstrating stability and resilience in the market.
The focus on health and aging demographics in Italy could drive further market expansion.
Technological advancements in hormone treatments and delivery methods could influence future growth.